Merck & Co., Inc. (6MK0)
FSX
Real-time Data
06:00 AM
Day's Range
20.4052 wk Range
10.60Overview - 6MK0 - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
376.44B
P/E (Trailing)
‪117.05‬
PEG Ratio
‪-0.89‬
Price / Sales (TTM)
‪4.54‬
Price / Book
‪10.95‬
EV / EBITDA
‪15.22‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
19.70B
Price stats
Beta
‪0.21‬
50-Day Avg
‪17.11‬
200-Day Avg
‪15.68‬
Dividends
Payout Ratio
‪269.32%‬
Frequency
Quarterly
Market Cap - 6MK0 - Merck & Co., Inc.
Peers - 6MK0 - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- 6MK0FSXMerck & Co., Inc.304.13BMarket Cap+41.50%52-week change117.06P/E (Trailing)‪4.76%‬Profit Margin
- LLYFSXEli Lilly and Company945.01BMarket Cap+40.22%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR888.80BMarket Cap+39.18%52-week change38.26P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson566.92BMarket Cap+35.24%52-week change31.88P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR520.56BMarket Cap+33.96%52-week change29.17P/E (Trailing)‪21.48%‬Profit Margin
- 4ABFSXAbbVie Inc.402.01BMarket Cap+22.14%52-week change75.13P/E (Trailing)‪9.80%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR364.00BMarket Cap+19.44%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
Profile Summary - 6MK0 - Merck & Co., Inc.
About
Merck & Co., Inc. is a leading global healthcare company specializing in the discovery, development, manufacturing, and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical segment features blockbuster drugs like Keytruda, a leading immuno-oncology treatment…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
